ELISpot And Fluorospot Assay Market 2030: North America’s 35.4% Share Leads
The global ELISpot and Fluorospot assay market was valued at USD 311.8 million in 2024 and is projected to reach USD 450.0 million by 2030, expanding at a CAGR of 6.3% from 2025 to 2030. This steady growth is driven by the increasing prevalence of chronic and infectious diseases, the expansion of drug discovery initiatives, and the rising utilization of these assays in both diagnostics and biomedical research. Additionally, growing application in pre-clinical and clinically regulated bioanalysis is contributing significantly to market expansion. ELISpot and Fluorospot assays play a critical role in evaluating immune responses, particularly in understanding how various diseases, including cancer, interact with the immune system. These assays are instrumental in detecting and analyzing naturally occurring tumor-reactive T-cells, which are key players in cancer immunotherapy. Their use spans across epitope mapping, identification of tumor antigens, and monitoring of vaccine-induced T an...